Further supporting the tumor suppressor role of SMAD3, its downregulation has been associated with acute T‐cell lymphoblastic leukemia, as well as gastric cancer (Han et al., 2004; Wolfraim et al., 2004). Here, SMAD3 is linked to neoplasm.